ACTIVE

WPHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

47,2 k €

+37.8% YoY

Gross margin

80,7 k €

+21.9% YoY

Equity

688,3 k €

+7.4% YoY

What does WPHARMA do?

WPHARMA is a Private limited company incorporated in 2008. Its main activity is: Activities of head offices. Its registered office is in Bornem.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0898.266.619

Incorporation

30/05/2008

Legal form

Private limited company

Registered office

Riddermoerstraat(BRA) 4
2880 Bornem · FlandreSee on map

Contributed capital

50 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

70100Activities of head offices· main 70100Activities of head offices

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	80,7 k €	+21.9%	66,2 k €	-24.5%	87,7 k €	-13.0%	100,8 k €	+13.0%	89,2 k €	+12.1%	79,5 k €	+12.8%	70,5 k €	-1.0%	71,2 k €	-28.7%	100 k €	+0.3%	99,7 k €	+0.9%	98,8 k €	+15.9%	85,3 k €	-7.6%	92,3 k €	+13.2%	81,6 k €	+35.0%	60,4 k €	-18.5%	74,1 k €	-33.7%	111,8 k €
EBITDA	80,4 k €	+21.9%	65,9 k €	-24.4%	87,2 k €	-13.2%	100,5 k €	+12.9%	89 k €	+12.3%	79,2 k €	+12.8%	70,2 k €	-1.1%	71 k €	-28.8%	99,7 k €	+0.4%	99,3 k €	+0.8%	98,6 k €	+15.9%	85,1 k €	-7.7%	92,1 k €	+13.2%	81,4 k €	+35.4%	60,1 k €	-18.7%	73,9 k €	-33.8%	111,6 k €
Operating result	80,4 k €	+21.9%	65,9 k €	-24.4%	87,2 k €	-13.2%	100,5 k €	+12.9%	89 k €	+12.3%	79,2 k €	+12.8%	70,2 k €	+9.4%	64,2 k €	-30.9%	93 k €	+0.4%	92,6 k €	+0.8%	91,8 k €	+17.2%	78,3 k €	-11.1%	88,1 k €	+16.2%	75,8 k €	+32.2%	57,4 k €	-19.4%	71,2 k €	-34.0%	107,9 k €
Net result	47,2 k €	+37.8%	34,3 k €	-31.7%	50,1 k €	-13.5%	58 k €	+18.6%	48,9 k €	+21.0%	40,4 k €	+14.1%	35,4 k €	+30.3%	27,1 k €	-37.1%	43,1 k €	+6.7%	40,4 k €	+15.2%	35,1 k €	+13.1%	31 k €	-16.4%	37,1 k €	+39.2%	26,6 k €	+42.1%	18,8 k €	-30.7%	27,1 k €	-28.4%	37,8 k €
Balance sheet
Equity	688,3 k €	+7.4%	641,1 k €	+5.6%	606,8 k €	+9.0%	556,7 k €	+11.6%	498,7 k €	+10.9%	449,8 k €	+9.9%	409,5 k €	+9.5%	374,1 k €	+7.8%	346,9 k €	+14.2%	303,8 k €	+15.3%	263,4 k €	+15.4%	228,3 k €	+15.7%	197,3 k €	+23.2%	160,2 k €	+19.9%	133,6 k €	+16.3%	114,8 k €	+30.8%	87,8 k €
Total assets	960,7 k €	-1.1%	971,1 k €	-2.4%	994,7 k €	+2.4%	971,4 k €	+1.2%	959,7 k €	+1.4%	946,3 k €	-0.5%	950,9 k €	-0.0%	951 k €	-2.0%	970,3 k €	-0.2%	972,2 k €	+0.3%	969 k €	-0.6%	974,9 k €	+2.7%	949,7 k €	+0.7%	943,2 k €	+0.7%	936,6 k €	+7.5%	871,1 k €	+1.4%	858,7 k €
Cash	22,9 k €	-46.2%	42,5 k €	+33.4%	31,9 k €		–		9,4 k €	+8.5%	8,7 k €		–		518,9 €	-97.4%	19,7 k €	-6.3%	21 k €	+199%	7 k €	+32.7%	5,3 k €		–		–		10,1 k €	-70.5%	34,3 k €	+72.1%	19,9 k €
Debts	268,6 k €	-17.6%	326,1 k €	-14.0%	379,3 k €	-8.6%	414,8 k €	-9.9%	460,3 k €	-7.2%	495,7 k €	-8.3%	540,7 k €	-5.9%	574,8 k €	-7.7%	622,6 k €	-6.7%	667,7 k €	-5.3%	704,9 k €	-5.3%	744,3 k €	-0.8%	750,1 k €	-3.4%	776,1 k €	-2.7%	797,6 k €	+5.8%	753,6 k €	-2.3%	770,9 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Wendy Pauwels

Director

Active

Ended mandates

Wendy Pauwels

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Wpauwels● Active	0426.128.621

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	24/07/2025	26/07/2024	19/07/2023	14/07/2022	20/07/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	30/06/2023	24/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

17 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	29/06/2026	Dutch	PDF
Abridged model	31/12/2024	27/06/2025	24/07/2025	Dutch	PDF
Micro model	31/12/2023	28/06/2024	26/07/2024	Dutch	PDF
Micro model	31/12/2022	30/06/2023	19/07/2023	Dutch	PDF
Micro model	31/12/2021	24/06/2022	14/07/2022	Dutch	PDF
Micro model	31/12/2020	25/06/2021	20/07/2021	Dutch	PDF
Micro model	31/12/2019	26/06/2020	16/07/2020	Dutch	PDF
Micro model	31/12/2018	28/06/2019	24/07/2019	Dutch	PDF
Micro model	31/12/2017	29/06/2018	25/07/2018	Dutch	PDF
Micro model	31/12/2016	30/06/2017	13/07/2017	Dutch	PDF
Abridged model	31/12/2015	24/06/2016	15/07/2016	Dutch	PDF
Abridged model	31/12/2014	26/06/2015	22/07/2015	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	22/07/2014	Dutch	PDF
Abridged model	31/12/2012	28/06/2013	19/07/2013	Dutch	PDF
Abridged model	31/12/2011	29/06/2012	24/07/2012	Dutch	PDF
Abridged model	31/12/2010	24/06/2011	25/07/2011	Dutch	PDF
Abridged model	31/12/2009	25/06/2010	20/07/2010	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Wendy Pauwels

Director

Active

Ended mandates

Wendy Pauwels

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates28/08/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/01/2012
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Other11/06/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202547,2 k €↑
2024
Annual accounts 202434,3 k €↓
2023
Annual accounts 202350,1 k €↓
2022
Annual accounts 202258 k €↑
2021
Annual accounts 202148,9 k €↑
2020
Annual accounts 202040,4 k €↑
2019
Annual accounts 201935,4 k €↑
2018
Annual accounts 201827,1 k €↓
2017
Annual accounts 201743,1 k €↑
2016
Annual accounts 201640,4 k €↑
2015
Annual accounts 201535,1 k €↑
2014
Annual accounts 201431 k €↓
2013
Annual accounts 201337,1 k €↑
2012
Annual accounts 201226,6 k €↑
2011
Annual accounts 201118,8 k €↓
2010
Annual accounts 201027,1 k €↓
2009
Annual accounts 200937,8 k €
30/05/2008
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

WPHARMA

Overview

What does WPHARMA do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline